Health experts issue caution over unapproved peptides as FDA weighs easing restrictions
The FDA is convening an advisory committee over the next two days to discuss whether compounding pharmacies can dispense seven unapproved peptides with a doctor's prescription for special medical conditions.
Some health experts are skeptical because of the lack of research.
Adam Yamaguchi reports. ...
이 뉴스, 어떠셨어요?
탭 한 번으로 반응 · 로그인 불필요
공식 발표 ↔ 진영별 보도
FDA's Strategy Document on Facilitating Chemistry, Manufacturing, and Controls Readiness for Products With Accelerated Clinical Development
Advisory Committee; Peripheral and Central Nervous System Drugs Advisory Committee; Termination and Reestablishment
The FDA is about to decide which peptides could soon become widely available in the U.S. Here’s what happens next.
What's the deal with peptides? The hyped market under US review
STAT+: FDA staff and peptide enthusiasts set to clash at advisory panel
FDA reviews peptide injections favored by RFK Jr. and wellness influencers